These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24568501)

  • 1. Institutional experience of interstitial brachytherapy for head and neck cancer with a comparison of high- and low dose rate practice.
    Mohanti BK; Sahai P; Thakar A; Sikka K; Bhasker S; Sharma A; Sharma S; Bahadur S
    Asian Pac J Cancer Prev; 2014; 15(2):813-8. PubMed ID: 24568501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of interstitial PDR brachytherapy in the treatment of oral and oropharyngeal cancer. A single-institute experience of 236 patients.
    Strnad V; Melzner W; Geiger M; Zenk J; Waldfahrer F; Lotter M; Ott O; Seeger A; Iro H; Sauer R
    Strahlenther Onkol; 2005 Dec; 181(12):762-7. PubMed ID: 16362785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
    Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a place for brachytherapy in the salvage treatment of cervical lymph node metastases of head and neck cancers?
    Bartochowska A; Skowronek J; Wierzbicka M; Leszczynska M; Szyfter W
    Brachytherapy; 2015; 14(6):933-8. PubMed ID: 26249122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers.
    Kupferman ME; Morrison WH; Santillan AA; Roberts D; Diaz EM; Garden AS; Weber R
    Cancer; 2007 May; 109(10):2052-7. PubMed ID: 17407106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of high dose rate interstitial boost brachytherapy after external beam radiation therapy in head and neck cancer--an Indian (single institutional) learning experience.
    Patra NB; Goswami J; Basu S; Chatterjee K; Sarkar SK
    Brachytherapy; 2009; 8(2):248-254. PubMed ID: 19230791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer.
    Pellizzon AC; dos Santos Novaes PE; Conte Maia MA; Ferrigno R; Fogarolli R; Salvajoli JV; Kowalski LP
    Head Neck; 2005 Dec; 27(12):1035-41. PubMed ID: 16114005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997.
    Grabenbauer GG; Rödel C; Brunner T; Schulze-Mosgau S; Strnad V; Müller RG; Iro H; Sauer R
    Strahlenther Onkol; 2001 Jul; 177(7):338-44. PubMed ID: 11505619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost.
    Embring A; Onjukka E; Mercke C; Lax I; Berglund A; Friesland S
    Radiat Oncol; 2023 Apr; 18(1):65. PubMed ID: 37029424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose brachytherapy for early stage penile cancer: a 20-year single-institution study (73 patients).
    Cordoba A; Escande A; Lopez S; Mortier L; Mirabel X; Coche-Déqueant B; Lartigau E
    Radiat Oncol; 2016 Jul; 11():96. PubMed ID: 27464910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer.
    Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K
    Radiother Oncol; 2003 Aug; 68(2):123-8. PubMed ID: 12972306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
    Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of efficacy and safety of low-dose-rate vs. high-dose-rate intraluminal brachytherapy boost in patients with superficial esophageal cancer.
    Tamaki T; Ishikawa H; Takahashi T; Tamaki Y; Kitamoto Y; Okamoto M; Noda SE; Katoh H; Shirai K; Sakurai H; Nakano T
    Brachytherapy; 2012; 11(2):130-6. PubMed ID: 21700506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
    Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial high-dose rate brachytherapy with iridium-192 in patients with oral squamous cell carcinoma.
    Friedrich RE; Krüll A; Hellner D; Schwarz R; Heyer D; Plambeck K; Schmelzle R
    J Craniomaxillofac Surg; 1995 Aug; 23(4):238-42. PubMed ID: 7560110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.
    Strnad V; Geiger M; Lotter M; Sauer R
    Brachytherapy; 2003; 2(3):158-63. PubMed ID: 15062138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.